Total Holdings
45
Portfolio diversification across 45 positions
HRTS
(NASDAQ)Tema Heart & Health ETF
$36.51-- (--)
Loading... - Market loading
HRTS ETF Holdings: Tema Heart & Health ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$54.78M
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
Tema
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 48 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 11.74% |
| 2 |  | UnitedHealth Group Incorporated | Stock | 5.60% |
| 3 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 5.54% |
| 4 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 5.26% |
| 5 |  | Thermo Fisher Scientific Inc | Stock | 4.48% |
| 6 |  | Merck & Co., Inc | Stock | 4.17% |
| 7 | O OTCQX:RHHBY | Roche Holding AG | Stock | 4.16% |
| 8 |  | Johnson & Johnson | Stock | 3.95% |
| 9 | O OTC:RHHBY | Roche Holding AG | Stock | 3.92% |
| 10 |  | Revolution Medicines, Inc | Stock | 3.46% |
| 11 | L LON:AZN | AstraZeneca PLC | Stock | 3.45% |
| 12 | L LSE:AZN | AstraZeneca PLC | Stock | 3.42% |
| 13 |  | Cytokinetics, Incorporated | Stock | 3.32% |
| 14 |  | Gilead Sciences, Inc. | Stock | 3.28% |
| 15 | S SWX:NOVN | Novartis AG | Stock | 3.27% |
| 16 |  | Abbott Laboratories | Stock | 2.95% |
| 17 |  | Danaher Corporation | Stock | 2.92% |
| 18 |  | BridgeBio Pharma, Inc | Stock | 2.76% |
| 19 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.75% |
| 20 |  | AbbVie Inc | Stock | 2.69% |
| 21 |  | Intuitive Surgical, Inc. | Stock | 2.37% |
| 22 |  | Bristol-Myers Squibb Company | Stock | 2.13% |
| 23 |  | Amgen Inc | Stock | 2.01% |
| 24 |  | Medtronic plc | Stock | 2.00% |
| 25 |  | DexCom, Inc. | Stock | 1.91% |
| 26 |  | McKesson Corporation | Stock | 1.83% |
| 27 |  | Teva Pharmaceutical Industries Limited | Stock | 1.77% |
| 28 |  | Regeneron Pharmaceuticals, Inc. | Stock | 1.74% |
| 29 |  | Madrigal Pharmaceuticals, Inc | Stock | 1.50% |
| 30 |  | Boston Scientific Corporation | Stock | 1.43% |
| 31 |  | Edwards Lifesciences Corporation | Stock | 1.30% |
| 32 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 1.14% |
| 33 |  | Xenon Pharmaceuticals Inc | Stock | 1.00% |
| 34 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.96% |
| 35 |  | Insulet Corporation | Stock | 0.84% |
| 36 |  | Scholar Rock Holding Corp | Stock | 0.83% |
| 37 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.83% |
| 38 |  | Insmed Incorporated | Stock | 0.67% |
| 39 | N NMFQS:FXFXX | First American Funds, Inc. - Treasury Obligations Fund | Cash | 0.59% |
| 40 |  | Stryker Corporation | Stock | 0.59% |
| 41 |  | Ionis Pharmaceuticals, Inc | Stock | 0.57% |
| 42 |  | MBX | Stock | 0.57% |
| 43 |  | Viking Therapeutics Inc | Stock | 0.54% |
| 44 |  | Stoke Therapeutics, Inc | Stock | 0.53% |
| 45 |  | Kailera Therapeutics, Inc. Common Stock | Stock | 0.46% |
| 46 | C CO:GUBRA | Gubra A/S | Stock | 0.44% |
| 47 | C CO:ZEAL | Zealand Pharma A/S | Stock | 0.43% |
| 48 |  | Intellia Therapeutics, Inc | Stock | 0.27% |
Frequently Asked Questions About Tema Heart & Health ETF Holdings
What are the top holdings in HRTS?
Tema Heart & Health ETF (HRTS) holds 45 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is HRTS's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review HRTS's holdings table to analyze concentration risk.
What is HRTS's sector allocation?
The Sector Allocation chart shows how HRTS distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does HRTS invest in?
HRTS's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is HRTS ETF?
HRTS's diversification can be assessed by reviewing its 45 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.